Incyte Corporation

Ameena R Gandhi

Henry Yue

April J A Hafalia

Monique G Yao

Mariah R Baughn

Yan Lu

Craig H Ison

Anita Swarnakar

Preeti G Lal

Y Tom Tang

Neil Burford

Vicki S Elliott

Li Ding

Olga Bandman

Dyung Aina M Lu

Danniel B Nguyen

Bridget A Warren

Junming Yang

Yuming Xu

Rajagopal Gururajan

Brendan M Duggan

Narinder K Chawla

Bao M Tran

Sally Lee

Madhusudan M Sanjanwala

Michael B Thornton

Michael Thorton

Cynthia D Honchell

Kimberly J Gietzen

Ernestine A Lee

Catherine M Tribouley

Ian J Forsythe

Narinder K Walia

Chandra S Arvizu

Wen Luo

Soo Yeun Lee

Uyen K Tran

Pei Jin

Reena Khare

Thomas W Richardson

Joseph P Marquis

Jayalaxmi Ramkumar

Shanya D Becha

Joana X Li

Amy D Wilson

Stephanie Kareht

Kavitha Thangavelu

Farrah A Khan

Kavitha Thangaveln

Narinder K Chawla-Walia

Janice K Au-Young

Jennifer L Policky

Vicki S Kaulback

Stephanie K Sapperstein

Debopriya Das

Liam Kearney

Jennifer L Hillman

Yalda Azimzai

Angelo M Delegeane

Roopa M Reddy

Gregory Marcus

John D Burrill

Mark L Borowsky

Roberto Hernandez

Vicki S Elliott Kaulback

Kurt A Zingler

Preeti G Lai

Jennifer A Griffin

Stephen Todd

Deborah A Kallick

The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.

Secreted proteins

Antibody to secreted polypeptide

Various embodiments of the invention provide human kinases and phosphatases (KPP) polypeptides and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Antibodies to human &#x3b2;-adrenergic receptor kinase

Human &#x3b2;-adrenergic receptor kinase polypeptide and methods

Various embodiments of the invention provide human kinases and phosphatases (KPP) and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.

Human &#x3b2;-adrenergic receptor kinase nucleic acid molecule

The invention provides human lipid metabolism enzymes (LME) and polynucleotides which identify and encode LME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of LME.

Human phospholipases

The invention provides human human kinases (PKIN) and polynucleotides which identify and encode PKIN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PKIN.

Human cAMP-dependent protein kinase beta-catalytic subunit

The invention provides human kinases and phosphatases (KAP) and polnucleotides which identify and encode KAP. The invention also provides expresson vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KAP.

Human protein phosphatase 2C

The invention provides a human cysteine proteases and polynucleotides which encode those proteases. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists, as well as methods for diagnosing, treating, or preventing disorders associated with aberrant expression of cysteine proteases.

Proteases

Growing community of inventors

San Francisco, CA, United States of America

Ameena R Gandhi